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Abstract
Introduction:  Pheochromocytoma is a chromaffin cell catecholamine-secreting tumour
originating from the adrenal medulla.
Case presentation: We report here an unusual presentation of pheochromocytoma with
secondary amenorrhoea and its resolution after medical treatment with the alpha adrenergic
blocker, Phenoxybenzamine.
Conclusion: Pheochromocytoma is a rare cause of secondary amenorrhoea.
Introduction
Pheochromocytomas are chromaffin cell catecholamine-
secreting tumours originating from the adrenal medulla.
They may present in a number of ways from an incidental
finding to that of the classical triad of episodic headache,
tachycardia and sweating due to hypersecretion of cate-
cholamines resulting in episodic hypertension[1]. How-
ever, secondary amenorrhea, potentially through
activation of alpha receptors, has not been reported as a
presentation.
Case presentation
A 35 year white Caucasian nulliparous female presented
to the fertility clinic with 18 months history of secondary
amenorrhoea that was ascribed to post pill amenorrhoea.
She had a regular menstrual cycle since the age of 15. At
the age of 18 she started taking the contraceptive pill and
she had a regular withdrawal bleeding every 28 days, but
amenorrhoea ensued following its cessation at the age of
33. There was also no history of eating disorder or recent
weight loss, no previous medical history and there was no
family history of relevance including autoimmune dis-
ease. She was a non smoker, who drank less than 10 units
of alcohol a week. Physical examination revealed a lady
with normal blood pressure of 128/78 mmHg, weight of
60 kg, height of 173 cm giving her a Body Mass Index of
20 kg/m2.
Her investigations in the fertility clinic revealed iron defi-
ciency anaemia, Hb 9.7 g/dl, microcytosis and a low ferri-
tin of 4 ug/L (15–30 Units). She had luteal phase FSH, LH,
oestradiol and progesterone of 7.9 iu/L (0–5), 3.0 i.u/L
(2–9), <70 pmol/L (150–1000) and 1 nmol/L, respec-
tively. Her prolactin was 220 mU/L (0–550) and testoster-
one was 1.3 nmol/L (0–4.1) while the free androgen
index was 3 (0–8) and SHBG was 42 nmol/L. Her liver
enzymes, electrolytes, urea and creatinine were all within
the normal range. Her ultrasound of the pelvis revealed
normal ovaries and normal endometrial thickness and
hysterosalpingography showed patent fallopian tubes.
Her iron deficiency anaemia was corrected by ferrous sul-
phate treatment. Induction of ovulation with clomiphene
150 mg for 5 days and two trials with gonadotrophins nei-
ther achieved pregnancy nor ovulation, with a complete
failure of oocytes response. Meanwhile, she underwent
investigations for the initial iron deficiency anaemia with
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gastroscopy and colonoscopy CT. The latter revealed an
incidental left adrenal mass of 3 cm in diameter that did
not show features typical of an adenoma. Two urinary 24
hour urinary fractionated catecholamines showed an
excess secretion of norepinephrine at 1567 and 1159
nmol/L (NR 70–550) with normal epinephrine and
dopamine secretion. She was treated initially with an esca-
lating dose of phenoxybenzamine starting at 10 mg twice
daily before adding propranolol slow release 80 mg daily
prior to undergoing surgery. Two weeks after starting the
phenoxybenzamine, she reported resumption of regular
menstrual periods after 24 months of secondary amenor-
rhoea. Definitive treatment in the form of laparoscopic
left adrenalectomy confirmed the presence of an encapsu-
lated pheochromocytoma that was completely excised.
Discussion
This unusual presentation of pheochromocytoma has not
been reported before. One possibility is that ovarian
granulsa luteal cells in the human and animal have alpha
and beta adrenergic receptors. It was shown recently that
activation of alpha adrenergic receptors causes inhibition
of LH and HCG mediated progesterone release[2] through
intracellular Ca++  and phosphoinositide pathways[2]
although at least in rats, the renin angiotensin system is
thought to play a role in mediating the effect of norepine-
phrine [3] in the ovary. In the group given Doxazocin,
there was a significant increase in serum progesterone and
ovarian renin angiotensin system soluble and membrane-
bound enzymes confirming that alpha adrenergic recep-
tors caused inhibition of progesterone release.
A less likely possibility is the interaction of norepine-
phrine at the level of the hypothalamus. There is animal
evidence that GnRH release and LH pulsatilty are modu-
lated by extrahypothalamic norepinephrine [4]. The
median pre-optic area of the hypothalamus is innervated
by ascending noradrenergic fibres from the locus coeru-
leus and these fibres stimulate GnRH and LH release [4].
Animal studies have shown that alpha adrenergic recep-
tors in the hypothalamus play a role in modulating GnRH
and LH release. In a study on rats, stimulating the ascend-
ing noradrenergic bundle has resulted in partial or com-
plete inhibition of the LH pulse pattern[5]. The
mechanism of this effect remains unknown[4]. However,
this was not found in human studies. As an example,
intravenous administration of the alpha adrenergic-block-
ing agent, phentolamine, in amounts sufficient to pro-
duce marked orthostatic hypotension in five normal men,
resulted in no alteration of LH secretory spike activity[6].
In our patient, the use of GnRH for induction of ovulation
was unsuccessful which suggests that the level of interfer-
ence by the excess tumorous norepinephrine was at the
ovary rather than the hypothalamus.
Conclusion
This case report illustrates a patient presented with amen-
orrhoea that was secondary to a pheochromocytoma, a
rare differential diagnosis for patients presenting with sec-
ondary amenorrhoea.
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